Evertogen Life Sciences Limited - Company Profile

It is a pharma public limited company based in Hyderabad, Telangana, India, established in 2013.

2013 Hyderabad, Telangana, India Active

Last Updated: January 11, 2026

About Evertogen Life Sciences Limited

Evertogen Life Sciences Limited, a active public limited company, was established on 11 January 2013 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232TG2013PLC085349. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹122.00 Cr and a paid-up capital of ₹119.14 Cr.

Formerly known as Optimus Generics Limited. It upholds a compliant status. Employing 265 professional, Its leadership includes Manav Jassal (Director), Subbarao Kattamuri (Managing Director), Sherifuddin Sheriff Shaik (Director). Past directors included Saritha Rani Premraj, Arun Prakash, Subbarao Kattamuri. It holds ₹135.17 Cr open charges and ₹36.51 Cr settled loans. Its latest AGM occurred on 09 September 2024, with the balance sheet filed on 31 March 2024. It is based at 7-2-C8 & C8/2, G V Chambers, Sanath Nagar Ida Sanath Nagar, Hyderabad, Telangana, 500018.

Company Details

CIN/LLPIN
U24232TG2013PLC085349
Registration Number
085349
Incorporation Date
11 January 2013
Authorized Capital
₹122.00 Cr
Paid-Up Capital
₹119.14 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 122.00 Cr as on 11-01-2026
Paid Up Capital ₹ 119.14 Cr as on 11-01-2026
Company Age 13 Year, 5 Months
Last Filing with ROC 31 Mar 2024
Open Charges ₹ 135.17 Cr as on 11-01-2026
Satisfied Charges ₹ 36.51 Cr as on 11-01-2026
Revenue Growth **** 54.51% (FY 2023)
Profit Growth **** 39.63% (FY 2023)
Ebitda **** 63.74% (FY 2023)
Net Worth -119.66% (FY 2023)
Total Assets **** 1.72% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Evertogen Life Sciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Evertogen Life Sciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manav Jassal	Director	11 Jan 2013	Current
Subbarao Kattamuri	Managing Director	11 Jan 2013	Current
Sherifuddin Sheriff Shaik	Director	06 Dec 2023	Current
Vikram Ravindra Mamidipudi	Director	27 Mar 2015	Current
Sushma Kattamuri	Director	05 Jan 2022	Current
Sat Paul Jassal	Director	18 Jun 2021	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Company Secretary	31 Aug 2020	Past
Pramod Abcsdd	Director	20 Jul 2020	Past
Pramod Abcsdd	Director	09 Feb 2013	Past
Pramod Abcsdd	Ceo(Kmp)	-	Past
Pramod Abcsdd	Cfo(Kmp)	-	Past
Pramod Abcsdd	Chief Financial Officer	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Evertogen Life Sciences.

Evertogen Life Sciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.51% increase. The company also saw a substantial improvement in profitability, with a 39.63% increase in profit. The company's net worth observed a substantial decline by a decrease of 119.66%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

54.51%

*******

Revenue from Operations

*******

54.45%

*******

Total Assets

*******

1.72%

*******

Profit or Loss

*******

39.63%

*******

Net Worth

*******

-119.66%

*******

EBITDA

*******

63.74%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Evertogen Life Sciences?

In 2023, Evertogen Life Sciences had a promoter holding of 100.00%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,351,704,043.00

Satisfied Charges

₹365,117,638.00

Charges Breakdown by Lending Institutions

Axis Bank Limited : 95.00 Cr
Hdfc Bank Limited : 37.30 Cr
Others : 2.87 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Apr 2022	Hdfc Bank Limited	₹37.30 Cr	Open
16 Sep 2020	Axis Bank Limited	₹5.20 Cr	Open
25 Aug 2020	Others	₹2.87 Cr	Open
07 Feb 2014	Axis Bank Limited	₹89.80 Cr	Open
29 Mar 2022	Others	₹20.00 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Evertogen Life Sciences?

Evertogen Life Sciences has a workforce of 265 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Evertogen Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Evertogen Life Sciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Evertogen Life Sciences

Recent Activity within the Organization

Director Appointment

Progress on Akhila Thotapally was appointed as a Company Secretary was appointed as a Company Secretary on 22 Jul 2025 & has been associated with this company since 11 months 13 days . was documented.
22 Jul 2025
Charges

The activity A charge registered on 29 Mar 2022 via Charge ID 100573842 with Others was fully satisfied on 01 Oct 2024. was completed.
01 Oct 2024
Charges

Progress on A charge with Hdfc Bank Limited of Rs. 37.30 Cr registered on 18 Apr 2022 with Charge ID 100568530 was modified on 23 Sep 2024. was documented.
23 Sep 2024
Annual General Meeting

Progress on Evertogen Life Sciences Limited last Annual general meeting of members was held on 09 Sep 2024 as per latest MCA records. was documented.
09 Sep 2024
Balance Sheet

The activity Evertogen Life Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
31 Mar 2024
Director Appointment

Progress on Sherifuddin Sheriff Shaik was appointed as a Director was appointed as a Director on 06 Dec 2023 & has been associated with this company since 2 years 6 months . was documented.
06 Dec 2023

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Evertogen Life Sciences Limited?

The CIN of Evertogen Life Sciences Limited is U24232TG2013PLC085349.

Where is Evertogen Life Sciences Limited headquartered?

Evertogen Life Sciences Limited is headquartered at 7-2-C8 & C8/2, G V Chambers, Sanath Nagar Ida Sanath Nagar, Hyderabad, Telangana, 500018.

When was Evertogen Life Sciences Limited incorporated?

Evertogen Life Sciences Limited was incorporated on 11 January 2013.

Who are the current directors of Evertogen Life Sciences Limited?

The current directors of Evertogen Life Sciences Limited are

What is the primary industry of Evertogen Life Sciences Limited?

The primary industry of Evertogen Life Sciences Limited is Manufacturing.

Is Evertogen Life Sciences Limited a listed company?

Evertogen Life Sciences Limited is unlisted.

What is the capital structure of Evertogen Life Sciences Limited?

The authorized capital of Evertogen Life Sciences Limited is ₹122.00 Cr, and the paid-up capital is ₹119.14 Cr.

What is the compliance status of Evertogen Life Sciences Limited?

The compliance status of Evertogen Life Sciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available